Prediction and Prevention of Postoperative Mortality and Morbidity | MicrobiomeTrials← Back to trialsNCT06042413
Prediction and Prevention of Postoperative Mortality and Morbidity
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-06Est. Completion: 2027-05
Enrollment target: 1,200 participants Locations- UPMC Montefiore Hospital, Pittsburgh, Pennsylvania, United States
- UPMC Presbyterian Hospital, Pittsburgh, Pennsylvania, United States
- UPMC Shadyside Hospital, Pittsburgh, Pennsylvania, United States
- UPMC Mercy Hospital, Pittsburgh, Pennsylvania, United States
- UPMC Passavant Hospital, Pittsburgh, Pennsylvania, United States
ContactDayana Alsamsam, BSPS, MSc
Other microbiome trials you might be interested in
Frontotemporal Dementia
This study is testing a new treatment for Frontotemporal Dementia (FTD) - a progressive brain disease that affects perso…
Multiple LocationsEst. completion Oct 31, 2027
Alzheimer Disease
This study will primarily investigate the safety and secondarily the effect and applicability of Transcranial Pulse Wave…
Potsdam, GermanyEst. completion Oct 1, 2026
Moderate to Severe Alzheimer's Disease
The objective of this study is to evaluate the safety and efficacy of GV1001 administered subcutaneously in patients wit…
Multiple LocationsEst. completion Jan 2028